United Therapeutics Corporation (UTHR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 21.59B |
| Enterprise Value | 20.07B |
| P/E Ratio | 20.79 |
| PEG Ratio | 118.57 |
| Price/Sales Ratio | 7.93 |
| Price/Book Ratio | 4.04 |
| Enterprise/Revenue | 7.56 |
| Enterprise/EBITDA | 15.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.39 |
| Operating Margin | 0.41 |
| Return On Assets | 0.17 |
| Return On Equity | 0.19 |
| Revenue | 3.18B |
| Revenue/Share | 74.65 |
| Gross Profit | 2.8B |
| EBITDA | 1.82B |
| Net Income | 1.33B |
| Diluted EPS | 27.86 |
| Total Cash | 2.07B |
| Total Cash/Share | 48.43 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.61 |
| Book Value Per Share | 146.98 |
| 52-Week Change | 28.62 |
| 52-Week High | 614.23 |
| 52-Week Low | 455.63 |
| Moving Average 50 Days | 538.56 |
| Moving Average 200 Days | 536.21 |
| Average Volume | 704,803 |
| Shares Outstanding | 42.59M |
| % Held by Institutions | 98.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 23, 2009 |